Shobna Sawry to Antiretroviral Therapy, Highly Active
This is a "connection" page, showing publications Shobna Sawry has written about Antiretroviral Therapy, Highly Active.
Connection Strength
0,597
-
What Should We Do When HIV-positive Children Fail First-line Combination Antiretroviral Therapy? A Comparison of 4 ART Management Strategies. Pediatr Infect Dis J. 2019 04; 38(4):400-405.
Score: 0,132
-
Optimal timing of antiretroviral treatment initiation in HIV-positive children and adolescents: a multiregional analysis from Southern Africa, West Africa and Europe. Int J Epidemiol. 2017 04 01; 46(2):453-465.
Score: 0,115
-
Growth and Mortality Outcomes for Different Antiretroviral Therapy Initiation Criteria in Children Ages 1-5 Years: A Causal Modeling Analysis. Epidemiology. 2016 Mar; 27(2):237-46.
Score: 0,106
-
Virologic failure among children taking lopinavir/ritonavir-containing first-line antiretroviral therapy in South Africa. Pediatr Infect Dis J. 2015 Feb; 34(2):175-9.
Score: 0,099
-
The effect of tuberculosis treatment on virologic and immunologic response to combination antiretroviral therapy among South African children. J Acquir Immune Defic Syndr. 2014 Oct 01; 67(2):136-44.
Score: 0,096
-
Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome in children. Pediatr Pulmonol. 2016 Feb; 51(2):157-64.
Score: 0,025
-
Pharmacokinetics and safety of rifabutin in young HIV-infected children receiving rifabutin and lopinavir/ritonavir. J Antimicrob Chemother. 2015 Feb; 70(2):543-9.
Score: 0,024